Completed
Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease
NCT00733642
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Pfizer Investigational Site Glendale, California, United States
- Pfizer Investigational Site Eatontown, New Jersey, United States
- Pfizer Investigational Site Oakhurst, New Jersey, United States